Mark For: EVEREST™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88298203 |
Mark Literal Elements | EVEREST |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-07-30 |
Basis | 1(b) |
Class Status | ABANDONED |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Timothy J. Maier |
Attorney Docket Number | 12330003TM |
Law Office Assigned | N10 |
Employee Name | ZAK, HENRY S |
2019-02-12 | Application Filed |
2019-06-04 | Published |
2019-06-04 | Published for Opposition |
2019-07-30 | Location: INTENT TO USE SECTION |
2019-11-21 | Abandon |
2019-11-22 | Status: Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Tra |
2019-11-22 | Status: Dead/Abandoned |
2019-11-22 | Transaction Date |
Party: | Everest Cardiovascular, LLC |
Address | 14 Selsed Garth Lutherville, MARYLAND UNITED STATES 21093 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2019-02-12 |
TEAS RF New Application | MULTI | 2019-02-12 |
XSearch Search Summary | XML | 2019-04-24 |
XSearch Search Summary | XML | 2019-04-24 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-04-25 |
Notice of Publication | XML | 2019-05-15 |
Notification Of Notice of Publication | XML | 2019-05-15 |
OG Publication Confirmation | XML | 2019-06-04 |
Notice of Allowance | XML | 2019-07-30 |
Express Abandonment | XML | 2019-11-21 |
TEAS Rev, App and/or COA of Atty/Dom.Rep | XML | 2019-11-21 |
Notice of Abandonment | XML | 2019-11-22 |
(ABANDONED)
IC 042. US 100 101. G & S: Research and development of implantable artificial cardiac valves; research and development of medical apparatus and instruments for use in percutaneous and endovascular procedures in the cardiac field; research and development of medical devices consisting of delivery system for artificial cardiac valves; research and development of instruments for use in cardiovascular procedures; research and development of medical apparatus and instruments for treating cardiovascular disease; research and development of cardiac valves for surgical prostheses; research and development of prostheses for cardiovascular systems, namely, for the heart and heart valves; research and development of artificial cardiac valves for implantation as part of the cardiovascular system; research and development of percutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; research and development of valve implants consisting of artificial materials for implementation as part of the cardiovascular system; research and development of prosthetic and bioprosthetic heart valves; research and development of heart valve prostheses
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Research and development of implantable artificial cardiac valves; research and development of medical apparatus and instruments for use in percutaneous and endovascular procedures in the cardiac field; research and development of medical devices consisting of delivery system for artificial cardiac valves; research and development of instruments for use in cardiovascular procedures; research and development of medical apparatus and instruments for treating cardiovascular disease; research and development of cardiac valves for surgical prostheses; research and development of prostheses for cardiovascular systems, namely, for the heart and heart valves; research and development of artificial cardiac valves for implantation as part of the cardiovascular system; research and development of percutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; research and development of valve implants consisting of artificial materials for implementation as part of the cardiovascular system; research and development of prosthetic and bioprosthetic heart valves; research and development of heart valve prostheses |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | 2019-11-22 | |
ABANDONMENT - AFTER PUBLICATION | 2019-11-22 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-11-21 | |
TEAS EXPRESS ABANDONMENT RECEIVED | 2019-11-21 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-11-21 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-07-30 | |
PUBLISHED FOR OPPOSITION | 2019-06-04 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-06-04 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-05-15 | |
ASSIGNED TO EXAMINER | 2019-04-24 | 62126 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-04-24 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-06 | |
NEW APPLICATION ENTERED IN TRAM | 2019-02-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.